Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07909902Phase 3Completed
A Phase 3 trial of CZ1S in postoperative pain, sponsored by Zhejiang Cuize Pharmaceutical Technology. Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07909902.